In addition, Fantone et al. [4] have indicated that SLC7A11 (also known as xCT) expression is significantly upregulated in ovarian cancers, resulting in the inhibition of ferroptosis, enhancing cancer cell proliferation, invasion, and chemoresistance. The gene discussed is SLC7A11; the disease is ovarian carcinoma.